ATE265685T1 - Verbesserter blutgerinnungstest - Google Patents
Verbesserter blutgerinnungstestInfo
- Publication number
- ATE265685T1 ATE265685T1 AT99903537T AT99903537T ATE265685T1 AT E265685 T1 ATE265685 T1 AT E265685T1 AT 99903537 T AT99903537 T AT 99903537T AT 99903537 T AT99903537 T AT 99903537T AT E265685 T1 ATE265685 T1 AT E265685T1
- Authority
- AT
- Austria
- Prior art keywords
- plasma sample
- coagulation
- reagent
- factor
- protein
- Prior art date
Links
- 230000023555 blood coagulation Effects 0.000 title 1
- 230000015271 coagulation Effects 0.000 abstract 5
- 238000005345 coagulation Methods 0.000 abstract 5
- 239000003153 chemical reaction reagent Substances 0.000 abstract 3
- 101800004937 Protein C Proteins 0.000 abstract 2
- 102100036546 Salivary acidic proline-rich phosphoprotein 1/2 Human genes 0.000 abstract 2
- 101800001700 Saposin-D Proteins 0.000 abstract 2
- 229960000856 protein c Drugs 0.000 abstract 2
- 102000004411 Antithrombin III Human genes 0.000 abstract 1
- 108090000935 Antithrombin III Proteins 0.000 abstract 1
- 108010014172 Factor V Proteins 0.000 abstract 1
- 108010014173 Factor X Proteins 0.000 abstract 1
- 108010074860 Factor Xa Proteins 0.000 abstract 1
- 102000004032 Heparin Cofactor II Human genes 0.000 abstract 1
- 108090000481 Heparin Cofactor II Proteins 0.000 abstract 1
- 101710111620 Protein C activator Proteins 0.000 abstract 1
- 108010094028 Prothrombin Proteins 0.000 abstract 1
- 102100027378 Prothrombin Human genes 0.000 abstract 1
- 108090000190 Thrombin Proteins 0.000 abstract 1
- 229960005348 antithrombin iii Drugs 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 230000001771 impaired effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000011533 pre-incubation Methods 0.000 abstract 1
- 229940039716 prothrombin Drugs 0.000 abstract 1
- 229960004072 thrombin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/4609—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
- G01N2333/4613—Snake venom
- G01N2333/462—Snake venom from Agkistrodon sp., e.g. acutase, ACTE
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP1596A AUPP159698A0 (en) | 1998-02-02 | 1998-02-02 | Improved blood coagulation test |
| PCT/AU1999/000069 WO1999039212A1 (en) | 1998-02-02 | 1999-02-01 | Improved blood coagulation test |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE265685T1 true ATE265685T1 (de) | 2004-05-15 |
Family
ID=3805873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99903537T ATE265685T1 (de) | 1998-02-02 | 1999-02-01 | Verbesserter blutgerinnungstest |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6838251B1 (de) |
| EP (1) | EP1068536B1 (de) |
| JP (1) | JP4331891B2 (de) |
| AT (1) | ATE265685T1 (de) |
| AU (1) | AUPP159698A0 (de) |
| CA (1) | CA2318250A1 (de) |
| DE (1) | DE69916816T2 (de) |
| ES (1) | ES2217739T3 (de) |
| WO (1) | WO1999039212A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT947585E (pt) * | 1998-03-19 | 2001-11-30 | Instrumentation Lab Spa | Metodo in vitro melhorado, kits e reagentes para a peaquisa de defeitos de coagulacao sanguinea |
| EP1367135A1 (de) | 2002-05-29 | 2003-12-03 | Pentapharm AG | Verbessertes Verfahren zur Beurteilung der Thrombinbildung in Blutplasma |
| US7245215B2 (en) * | 2005-02-10 | 2007-07-17 | Pinc Solutions | Position-tracking device for position-tracking system |
| CN102692511B (zh) * | 2012-06-08 | 2015-04-15 | 上海太阳生物技术有限公司 | 蛋白c(pc)测定试剂盒(发色底物法) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3607559A1 (de) * | 1986-03-07 | 1987-09-10 | Boehringer Mannheim Gmbh | Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet |
| DE3724443A1 (de) * | 1987-07-23 | 1989-02-02 | Max Planck Gesellschaft | Funktioneller test zur bestimmung der protein s-aktivitaet |
| SE464135B (sv) * | 1989-07-14 | 1991-03-11 | Kabivitrum Ab | Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov |
| US5601995A (en) * | 1992-09-04 | 1997-02-11 | Gradipore Limited | Apparatus and method for detecting coagulation in blood samples |
| DE59410041D1 (de) * | 1993-12-03 | 2002-03-21 | Baxter Ag | Test zur Bestimmung der Empfindlichkeit gegenüber aktiviertem Protein C |
| AUPM731394A0 (en) * | 1994-08-05 | 1994-09-01 | Life Therapeutics Limited | Improved activated protein c resistance test |
| DE4427785A1 (de) * | 1994-08-08 | 1996-02-15 | Behringwerke Ag | Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems |
| US5780255A (en) * | 1995-06-09 | 1998-07-14 | Instrumentation Laboratory, S.P.A. | Protein C pathway screening test |
| FR2764389B1 (fr) * | 1997-06-06 | 1999-08-06 | Stago Diagnostica | Utilisation de venin de crotalus viridis helleri, procede et necessaire pour la determination de la reactivite de la proteine c activee |
-
1998
- 1998-02-02 AU AUPP1596A patent/AUPP159698A0/en not_active Abandoned
-
1999
- 1999-02-01 AT AT99903537T patent/ATE265685T1/de not_active IP Right Cessation
- 1999-02-01 DE DE69916816T patent/DE69916816T2/de not_active Expired - Lifetime
- 1999-02-01 JP JP2000529615A patent/JP4331891B2/ja not_active Expired - Lifetime
- 1999-02-01 ES ES99903537T patent/ES2217739T3/es not_active Expired - Lifetime
- 1999-02-01 WO PCT/AU1999/000069 patent/WO1999039212A1/en not_active Ceased
- 1999-02-01 CA CA002318250A patent/CA2318250A1/en not_active Abandoned
- 1999-02-01 US US09/601,073 patent/US6838251B1/en not_active Expired - Lifetime
- 1999-02-01 EP EP99903537A patent/EP1068536B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6838251B1 (en) | 2005-01-04 |
| CA2318250A1 (en) | 1999-08-05 |
| AUPP159698A0 (en) | 1998-02-26 |
| DE69916816T2 (de) | 2004-09-30 |
| DE69916816D1 (de) | 2004-06-03 |
| ES2217739T3 (es) | 2004-11-01 |
| JP4331891B2 (ja) | 2009-09-16 |
| JP2002502040A (ja) | 2002-01-22 |
| WO1999039212A1 (en) | 1999-08-05 |
| EP1068536A4 (de) | 2002-09-04 |
| EP1068536B1 (de) | 2004-04-28 |
| EP1068536A1 (de) | 2001-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lange et al. | Ecarin chromogenic assay–a new method for quantitative determination of direct thrombin inhibitors like hirudin | |
| Hemker et al. | Thrombin generation in plasma: its assessment via the endogenous thrombin potential | |
| AU751525B2 (en) | Method for determining the anticoagulatory potential of a sample | |
| JP4762472B2 (ja) | 血液学的アッセイ及び試薬 | |
| Lippi et al. | Activated partial thromboplastin time: new tricks for an old dogma | |
| US20090087870A1 (en) | Hematological assay and kit | |
| DE69021849D1 (de) | Verfahren zur Bestimmung des Spiegels von exogenen und endogenen Gerinnungsfaktoren und von Protein C. | |
| Walenga et al. | The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activity | |
| US5292664A (en) | Functional test and reagent for determining fibrinogen | |
| DE69832628D1 (de) | Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz | |
| WO2002034110A3 (en) | Method of determining global coagulability and hemostatic potential | |
| JPH11225796A5 (de) | ||
| AU1538202A (en) | A reagent and kit for determining global coagulability and hemostatic potential | |
| Raffa et al. | Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis | |
| ATE265685T1 (de) | Verbesserter blutgerinnungstest | |
| Antovic et al. | Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assay | |
| US5753510A (en) | Calibrator for use in test methods for detecting a defective coagulation factor V | |
| Eichinger | Thrombin generation and venous thromboembolism | |
| GB2368642A (en) | Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response | |
| GB2396915A (en) | Method for detecting procoagulant conditions | |
| Toulon et al. | ProC global: a new assay to evaluate the functionality of the protein C anticoagulant pathway preliminary results in 223 consecutive patients with a history of venous thromboembolism | |
| Demir et al. | Ecarin clotting time is sensitive to heparinoids: comparison of two different techniques | |
| Andresen et al. | Coagulation Inhibitor Potential: a study of assay variables | |
| WO2025186634A8 (en) | Method and kit for monitoring anticoagulant therapy | |
| US20030190692A1 (en) | Method for measuring the activity of the blood clotting factor XIIIA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties | ||
| EEWE | Authorization for restitution | ||
| UEP | Publication of translation of european patent specification |
Ref document number: 1068536 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |